Novavax
NVAX
$4.09
Share price
3.54%
Change (1 day)
-46.68%
Change (1 year)
Categories
EPS for Novavax (NVAX)
EPS in 2023 (TTM): -$7.19
According to Novavax's latest financial reports the company's current EPS (TTM) is -$7.19. In 2022 the company made an earnings per share (EPS) of -$8.30 an increase over its 2021 EPS that were of -$23.29.
EPS history for Novavax from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$7.19 | -13.37% |
| 2022 | -$8.30 | -64.36% |
| 2021 | -$23.29 | 243% |
| 2020 | -$6.79 | 19.75% |
| 2019 | -$5.67 | -43.86% |
| 2018 | -$10.10 | -19.84% |
| 2017 | -$12.60 | -38.83% |
| 2016 | -$20.60 | 74.58% |
| 2015 | -$11.80 | 63.89% |
| 2014 | -$7.20 | 16.13% |
| 2013 | -$6.20 | 40.91% |
| 2012 | -$4.40 | 29.41% |
| 2011 | -$3.40 | -50% |
| 2010 | -$6.80 | -27.66% |
| 2009 | -$9.40 | -11.32% |
| 2008 | -$10.60 | -7.02% |
| 2007 | -$11.40 | 46.15% |
| 2006 | -$7.80 | 50% |
| 2005 | -$5.20 | -63.38% |
| 2004 | -$14.20 | 20.34% |
| 2003 | -$11.80 | -35.87% |
| 2002 | -$18.40 | 113.95% |
| 2001 | -$8.60 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $3.74 | -152.02% | 🇨🇭 Switzerland |
 Pfizer PFE | $1.86 | -125.87% | 🇺🇸 USA |
 AstraZeneca AZN | $1.98 | -127.61% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $3.50 | -148.69% | 🇬🇧 UK |
 Sarepta Therapeutics
SRPT | -$7.83 | 8.90% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | -$2.40 | -66.62% | 🇺🇸 USA |
 Agenus
AGEN | -$0.85 | -88.18% | 🇺🇸 USA |
 NanoViricides NNVC | -$0.59 | -91.79% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | -$1.25 | -82.61% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | -$12.08 | 68.01% | 🇺🇸 USA |